Professor Victor Dzau

Victor Dzau is James B. Duke Distinguished Professor, Chancellor Emeritus and Director of Mandel Center at Duke University, and past President of the U.S. National Academy of Medicine (NAM). Previously, he was professor and chairman of medicine at both Harvard and Stanford Universities. He is recognized globally for a highly decorated career as a physician scientist and leader. His research laid the foundation for lifesaving drugs known as ACE inhibitors. He pioneered gene therapy and cardiac regeneration. Dzau has devoted his career to scientific innovation, global health, and equity. At the NAM, he has led initiatives on a global health risk framework, human gene editing, emerging science, technology and responsible innovation and climate change and health.

Dzau has served in leadership roles in global health. He co-chairs the G20 High-Level Panel on Pandemic Financing, Regional Vaccine Manufacturing Collaborative, and IPPS Science and Technology Expert Panel. He serves on the Global Preparedness Monitoring Board, co-chaired the G20 Scientific Panel on Global Health Security, and advised the G7 Hiroshima Health Task Force.